SU1295993A3 - Способ получени средства на основе производных 4-окси-2 @ -1,2-бензотиазин-3-карбоксамид-1,1-диоксида - Google Patents

Способ получени средства на основе производных 4-окси-2 @ -1,2-бензотиазин-3-карбоксамид-1,1-диоксида Download PDF

Info

Publication number
SU1295993A3
SU1295993A3 SU833589549A SU3589549A SU1295993A3 SU 1295993 A3 SU1295993 A3 SU 1295993A3 SU 833589549 A SU833589549 A SU 833589549A SU 3589549 A SU3589549 A SU 3589549A SU 1295993 A3 SU1295993 A3 SU 1295993A3
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
isoxicam
distilled water
oder
peg
Prior art date
Application number
SU833589549A
Other languages
English (en)
Russian (ru)
Inventor
Гебхардт Уве
Аугарт Гельмут
Кнехт Адольф
Original Assignee
Гедеке Аг,Западный Берлин (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гедеке Аг,Западный Берлин (Фирма) filed Critical Гедеке Аг,Западный Берлин (Фирма)
Application granted granted Critical
Publication of SU1295993A3 publication Critical patent/SU1295993A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
SU833589549A 1982-05-08 1983-05-05 Способ получени средства на основе производных 4-окси-2 @ -1,2-бензотиазин-3-карбоксамид-1,1-диоксида SU1295993A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3217315A DE3217315C2 (de) 1982-05-08 1982-05-08 Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Publications (1)

Publication Number Publication Date
SU1295993A3 true SU1295993A3 (ru) 1987-03-07

Family

ID=6163066

Family Applications (1)

Application Number Title Priority Date Filing Date
SU833589549A SU1295993A3 (ru) 1982-05-08 1983-05-05 Способ получени средства на основе производных 4-окси-2 @ -1,2-бензотиазин-3-карбоксамид-1,1-диоксида

Country Status (23)

Country Link
US (1) US4482554A (enExample)
EP (1) EP0093999B1 (enExample)
JP (1) JPS5931713A (enExample)
KR (1) KR900008441B1 (enExample)
AR (1) AR230634A1 (enExample)
AT (1) ATE29383T1 (enExample)
AU (1) AU551337B2 (enExample)
CA (1) CA1204668A (enExample)
DD (1) DD211484A5 (enExample)
DE (2) DE3217315C2 (enExample)
DK (1) DK157731C (enExample)
ES (1) ES8405274A1 (enExample)
FI (1) FI79944C (enExample)
GR (1) GR77503B (enExample)
HU (1) HU197208B (enExample)
IE (1) IE54729B1 (enExample)
IL (1) IL68421A (enExample)
NO (1) NO163314C (enExample)
NZ (1) NZ204086A (enExample)
PH (2) PH22726A (enExample)
SU (1) SU1295993A3 (enExample)
YU (1) YU90383A (enExample)
ZA (1) ZA832816B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3435843A1 (de) * 1984-09-29 1986-04-03 Gödecke AG, 1000 Berlin Antirheumatisch wirksame suppositorien
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
JPH0430634Y2 (enExample) * 1985-06-10 1992-07-23
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
EP0560900B1 (en) * 1990-12-03 1995-02-08 Vestar, Inc. Prevention of synovial adhesions
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
US6369328B1 (en) 1998-03-14 2002-04-09 The Furukawa Electric Co., Ltd. Heat dissipating device for transmission line, transmission line with heat dissipating device, and method for fitting heat dissipating device to transmission line
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (enExample) * 1967-05-18 1900-01-01
SE421792B (sv) * 1976-01-12 1982-02-01 Pfizer Forfarande for framstellning av n-(2-pyridyl)-4-hydroxi-2-metyl-2h-1,2-benso-tiazin-3-karboxamid-1,1-dioxid
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Европейский патент № 2482, кл. С 07 D 417/12, 1979. *

Also Published As

Publication number Publication date
JPH0257049B2 (enExample) 1990-12-03
PH24334A (en) 1990-05-29
FI79944C (fi) 1990-04-10
IE830785L (en) 1983-11-08
IL68421A0 (en) 1983-07-31
DK204683A (da) 1983-11-09
EP0093999A2 (de) 1983-11-16
PH22726A (en) 1988-11-28
NO831610L (no) 1983-11-09
NO163314C (no) 1990-05-09
DK157731C (da) 1990-07-16
FI831534L (fi) 1983-11-09
EP0093999B1 (de) 1987-09-09
NO163314B (no) 1990-01-29
DE3373414D1 (en) 1987-10-15
DE3217315A1 (de) 1983-11-10
ATE29383T1 (de) 1987-09-15
AU551337B2 (en) 1986-04-24
ES522107A0 (es) 1984-06-01
ES8405274A1 (es) 1984-06-01
IL68421A (en) 1986-04-29
IE54729B1 (en) 1990-01-17
DK157731B (da) 1990-02-12
DD211484A5 (de) 1984-07-18
NZ204086A (en) 1986-02-21
DK204683D0 (da) 1983-05-06
KR900008441B1 (ko) 1990-11-22
US4482554A (en) 1984-11-13
AU1366483A (en) 1983-11-10
CA1204668A (en) 1986-05-20
GR77503B (enExample) 1984-09-24
JPS5931713A (ja) 1984-02-20
EP0093999A3 (en) 1985-05-15
FI79944B (fi) 1989-12-29
DE3217315C2 (de) 1986-05-22
FI831534A0 (fi) 1983-05-04
KR840004509A (ko) 1984-10-22
YU90383A (en) 1988-02-29
AR230634A1 (es) 1984-05-31
ZA832816B (en) 1983-12-28
HU197208B (en) 1989-03-28

Similar Documents

Publication Publication Date Title
KR900008441B1 (ko) 옥시캄 유도체를 함유하는 제약조성물의 제조방법
DE69728783T2 (de) Verbesserte arzneimittel
FI87993B (fi) Foerfarande foer framstaellning av alkaliska injektionsloesningar av torasemid innehaollande vatten, som aer faerdiga foer injicering
WO2023109801A1 (zh) 一种可用于亲脂性药物递送的超分子水凝胶及其制备方法和用途
KR20210007951A (ko) 멜록시캄 조성물, 제제 및 이의 제조 방법 및 응용
DE3536902A1 (de) Verfahren zur mikrokapselung durch phasentrennung von wasserloeslichen arzneimittelsubstanzen
US4128632A (en) Solubilization of Rafoxanide
FR2482458A1 (fr) Compositions antitumorales a base de methanesulfon-m-anisidine
JPH0674212B2 (ja) 塩化ベンザルコニウム含有水性製剤の配合禁忌防止方法
RU2096043C1 (ru) Антигипоксическое средство и способ его получения
DE69835165T2 (de) Pharmazeutische Formulierung, die Glycin als Stabilisator umfasst
US4133879A (en) Process for producing stable solutions of a sulphonamide and a potentiator
EP0318906B1 (en) Lyophilized preparation of platinum compound
RU2443432C2 (ru) Фармацевтическая композиция для введения инъекцией
FR2740973A1 (fr) Nouvelle forme d'administration de l'hydroxocobalamine et son utilisation dans les intoxications par les cyanures
US4088759A (en) Injectable pharmaceutical solutions
KR100228752B1 (ko) 난용성 약물인 비페닐디메틸디카르복실레이트를 주성분으로 함유하는 액제 및 그 제조방법
EP2346599B1 (fr) Vesicules catanioniques, leur procede de preparation et leurs applications
RU2310663C1 (ru) Способ приготовления композиций липосом с гелями, синтезированными из цистеина и нитрата серебра
CN1589795A (zh) 尼莫地平冻干组合物及其制备方法
JPH11193234A (ja) ニカルジピンの液状医薬品製剤
DE343323C (enExample)
JPS6061519A (ja) 注射しうるｂｂｍ−９２８ａ組成物
DE3010002A1 (de) Prostaglandine enthaltende pharmazeutische zubereitung
CH370802A (de) Verfahren zur Herstellung quaternärer Ammoniumsalze